Predicting factors of clomiphene citrate responsiveness in infertile women with normogonadotropic anovulation (WHO group II anovulation)
Background: Clomiphene responsiveness has been varied in WHO group II anovulatory patients. Our study evaluates factors associated with clomiphene citrate responsiveness in this population. Various parameters were studied, including anthropometric, hormonal and transvaginal ultrasonographic measurem...
Main Authors: | Theeraporn Areetheerapas, Artitaya Singwongsa, Komsun Suwannarurk, Junya Pattaraarchachai |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-02-01
|
Series: | Clinical and Experimental Obstetrics & Gynecology |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/CEOG/49/2/10.31083/j.ceog4902039 |
Similar Items
-
Clomiphene Citrate versus Letrozole in the Treatment of Anovulatory Infertility: A Randomized Controlled Trial
by: M. C. Gihan, et al.
Published: (2022-08-01) -
Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention?
by: Ying Liang, et al.
Published: (2021-04-01) -
Randomized interventional clinical trial to estimate the efficacy of clomiphene citrate versus letrozole in induction of ovulation in infertility
by: Yogindra Kumar Manohar Kabadi, et al.
Published: (2022-07-01) -
The impact of letrozole versus clomiphene citrate on uterine blood flow in patients with unexplained infertility.
by: Nahid Sakhavar, et al.
Published: (2014-03-01) -
Induction of ovulation with clomiphene citrate combined with bromocriptine in polycystic ovary syndrome patients with infertility: A prospective, randomized, and controlled clinical trial
by: Hai-Yun Guan, et al.
Published: (2017-01-01)